spondyloarthropathy: A group of inflammatory rheumatic diseases associated with arthritis and enthesitis, and often involving the axial skeleton. The most common form of spondyloarthritis is ankylosing spondylitis. Other forms include axial spondyloarthritis, peripheral spondyloarthritis, reactive arthritis, psoriatic arthritis/spondylitis and enteropathic arthritis/spondylitis.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
115 |
4. Check minimum number of eventsNone |
115 |
5. Include endpointsNone |
115 |
6. Filter based on genotype QC (FinnGen only) |
115 |
Control definitions (FinnGen only)
- Control exclude
- M13_DORSOPATHY
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M46
- Name in latin
- Osteomyelitis vertebrae
Similar endpoints
↥List of similar endpoints to
Osteomyelitis of vertebra
based on the number of shared cases.
Similar with more cases:
- Autoimmune diseases related-to ILD
- Spondylopathies
- Dorsopathies
- Diseases of the musculoskeletal system and connective tissue
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 937 | 363 | 565 |
| Only index persons | 806 | 323 | 483 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.02 |
| Only index persons | 0.02 | 0.01 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 63.49 | 65.55 | 62.11 |
| Only index persons | 62.54 | 64.59 | 61.16 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 115 | 40 | 75 |
| Unadjusted period prevalence (%) | 0.03 | 0.01 | 0.03 |
| Median age at first event (years) | 63.56 | 59.04 | 65.98 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 108
- Matched controls
- 1079
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M46.2
ICD-10 Finland
Osteomyelitis of vertebra
+∞
155.8
108
*
M46.3
ICD-10 Finland
Infection of intervertebral disc (pyogenic)
+∞
35.4
32
*
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
224.3
32.7
32
*
M46.4
ICD-10 Finland
Discitis, unspecified
+∞
31.8
29
*
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
78.2
26.6
29
5
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
21.3
20.3
30
19
M48.0
ICD-10 Finland
Spinal stenosis
242.7
20.3
20
*
J01MA12
ATC
levofloxacin; systemic
6.9
17.4
52
127
N02AA05
ATC
oxycodone; systemic
8.7
15.9
37
61
N03AX16
ATC
pregabalin; oral
7.4
15.8
42
85
N02AX02
ATC
tramadol; systemic, rectal
5.5
15.6
65
232
M54.5
ICD-10 Finland
Low back pain
6.5
15.1
46
111
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
172.4
14.9
15
*
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
49.9
14.6
17
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
13.8
14.5
25
23
GD1AA
NOMESCO Finland
Thorax X-ray examination
5.1
14.4
74
321
J01FF01
ATC
clindamycin; systemic
5.5
14.3
54
167
A49.9
ICD-10 Finland
Bacterial infection, unspecified
7.9
14.0
34
59
J04AB02
ATC
rifampicin; systemic
46.4
13.6
16
*
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
+∞
12.7
12
*
M54.9
ICD-10 Finland
Dorsalgia, unspecified
11.4
12.3
23
25
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
26.5
12.0
16
7
A41.9
ICD-10 Finland
Sepsis, unspecified
12.7
11.9
21
20
N06AX21
ATC
duloxetine; oral
10.7
11.5
22
25
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
4.4
10.4
45
151
N03AX12
ATC
gabapentin; oral
7.8
9.6
22
34
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
109.2
9.6
10
*
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
+∞
9.5
9
*
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
+∞
9.5
9
*
UJF32
NOMESCO Finland
Coloscopy
4.2
9.4
41
136
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.0
9.3
44
157
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.9
8.9
44
160
L28
ICPC
Limited function/disability (L)
5.0
8.8
30
77
A40.8
ICD-10 Finland
Other streptococcal sepsis
54.5
8.8
10
*
M54.4
ICD-10 Finland
Lumbago with sciatica
7.7
8.7
20
31
L03
ICPC
Low back symptom/complaint
4.8
8.7
31
84
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
6.6
8.6
22
40
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
48.6
7.8
9
*
C03CA01
ATC
furosemide; systemic
3.4
7.7
48
207
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
12.1
7.5
13
12
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.2
7.5
30
90
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
6.5
7.5
19
34
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.5
7.5
17
26
G06.1
ICD-10 Finland
Intraspinal abscess and granuloma
+∞
7.4
7
*
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
+∞
7.4
7
*
N02BE01
ATC
paracetamol; systemic, rectal
4.8
7.4
98
724
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
32.4
7.3
9
*
R50.9
ICD-10 Finland
Fever, unspecified
4.4
7.2
27
76
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.9
7.2
31
100
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
15.1
7.1
11
8
N02AJ06
ATC
codeine and paracetamol; systemic
3.3
7.0
45
194
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
3.0
7.0
57
291
WX408
NOMESCO Finland
General anesthesy, balanced
3.4
6.9
39
154
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
42.8
6.9
8
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
7.0
6.8
16
26
AA1AD
NOMESCO Finland
CT of head and brain
3.6
6.6
34
123
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
15.6
6.5
10
7
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
74.0
6.5
7
*
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
12.1
6.5
11
10
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
28.5
6.3
8
*
A06AD11
ATC
lactulose; oral
4.4
6.3
23
63
205
Kela drug reimbursment
Chronic hypertension
3.0
6.3
43
194
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
+∞
6.3
6
*
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
+∞
6.3
6
*
7227C
ICD-9 Finland
Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]
+∞
6.3
6
*
J01CF02
ATC
cloxacillin; systemic
13.6
6.2
10
8
I50.9
ICD-10 Finland
Heart failure, unspecified
3.7
6.2
28
93
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
11.0
6.2
11
11
N03AE01
ATC
clonazepam; systemic
11.0
6.2
11
11
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
7.1
6.1
14
22
M03BX02
ATC
tizanidine; oral
2.7
6.1
66
394
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
16
13
14.14
16.37
10.9
6.3
mg/l
13.2
9.8
1.61
16
13
(3042936) Bacteria identified in Isolate by Culture
42
116
5.13
15.00
3.8
1.9
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
27
50
6.75
14.82
7.5
3.2
mmol/l
2.9
2.6
0.19
22
41
(42870588) Differential panel, method unspecified - Blood
70
297
4.47
14.17
11.3
5.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
64
259
4.32
13.72
13.0
4.3
—
—
—
0
0
(3009343) pH of Capillary blood
27
54
6.23
13.68
7.6
3.1
ph
7.3
7.4
—
5
8
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
20
29
8.14
13.61
2.1
2.5
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
13
10
14.53
13.59
3.9
1.6
mmol/l
1.7
1.6
—
13
10
(3021901) Oxygen saturation in Capillary blood
15
15
11.35
13.42
6.9
2.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
14
13
12.12
13.11
1.6
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
15
18
9.43
11.77
3.9
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
13
14
10.34
10.97
2.8
1.6
—
—
—
0
0
(3012501) Base excess in Blood by calculation
15
20
8.47
10.83
9.0
1.6
mmol/l
2.2
1.6
—
10
12
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
59
258
3.64
10.68
3.0
2.0
u/l
257.7
294.8
0.13
54
240
(3032080) INR in Blood by Coagulation assay
74
375
3.73
10.62
16.7
9.0
inr
1.3
1.3
0.15
30
119
(3002030) Lymphocytes/100 leukocytes in Blood
79
426
3.73
10.12
11.8
5.5
%
26.1
26.6
0.13
74
407
(1616796) Gas panel - Central venous blood
14
19
8.25
9.93
9.1
2.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
12
14
9.45
9.52
4.3
1.9
%
57.3
58.1
0.08
12
14
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
36
124
3.77
9.15
4.1
2.2
%
20.2
22.6
0.49
30
113
(3004588) Protein electrophoresis panel - Serum or Plasma
25
66
4.56
9.09
3.2
1.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
75
414
3.33
8.80
17.1
6.6
mmol/l
1.2
1.2
0.79
61
353
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
21
50
4.91
8.62
1.9
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
23
60
4.54
8.46
5.4
4.1
%
0.9
0.3
0.47
12
12
(3030905) Polymorphonuclear cells [#/volume] in Blood
11
14
8.58
8.13
4.2
1.9
e9/l
4.0
4.4
0.25
11
14
(3025159) Blasts/100 leukocytes in Blood
22
59
4.37
7.79
5.3
4.2
%
6.7
0.6
0.42
12
14
(3023520) Reticulocytes [#/volume] in Blood
27
85
3.84
7.71
2.8
2.9
e9/l
78.7
66.6
1.16
22
65
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
47
211
3.08
7.65
3.3
1.9
mg/l
3.3
3.1
0.25
37
182
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
22
6.53
7.56
1.6
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
30
103
3.59
7.55
8.8
2.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
39
159
3.20
7.46
3.5
1.8
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
11
7
17.17
7.39
3.6
1.3
%
91.8
86.8
—
11
7
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
42
180
3.10
7.37
2.2
1.8
pmol/l
599.1
416.5
1.86
32
145
(3026493) Urate [Moles/volume] in Serum or Plasma
49
233
2.92
7.11
4.3
2.8
umol/l
11147.3
4080.5
0.28
41
202
(3007853) Bacteria identified in Skin by Aerobe culture
25
79
3.77
7.07
3.2
1.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
22
64
4.01
6.97
5.9
4.0
%
0.0
0.3
1.26
13
18
(3003458) Phosphate [Moles/volume] in Serum or Plasma
35
139
3.18
6.95
12.1
5.3
mmol/l
1.1
1.1
0.53
35
126
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
14
28
5.55
6.90
2.5
1.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
23
70
3.86
6.85
5.9
3.9
%
0.8
1.2
0.41
13
22
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
23
71
3.80
6.71
5.0
3.3
mmol/l
1.2
1.2
2.56
23
62
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
61
334
2.76
6.68
5.2
2.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
60
326
2.76
6.66
5.9
3.2
e6/l
162.3
159.1
0.01
54
234
(3027945) Reticulocytes/100 erythrocytes in Blood
30
112
3.27
6.56
3.3
2.8
%
1.9
1.7
0.61
25
107
(40761536) Microorganisms panel - Urine sediment
23
73
3.69
6.44
10.9
3.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
12
22
5.97
6.44
2.7
1.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
48
237
2.76
6.36
6.8
2.9
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
38
167
2.90
6.26
2.7
1.6
nmol/l
1308.4
1124.2
0.61
28
127
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
11
19
6.30
6.23
1.2
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
87
586
2.99
6.16
7.4
3.9
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
13
27
5.30
6.14
2.5
1.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
61
346
2.62
6.06
4.6
2.3
ug/l
161.0
166.2
0.07
56
312
(3037756) Immunofixation for Serum or Plasma
11
20
5.98
5.93
2.3
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
20
62
3.69
5.77
2.2
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
16
42
4.26
5.76
7.3
2.8
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
17
6.35
5.73
1.6
1.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
78
508
2.66
5.70
17.9
10.0
e9/l
4.2
4.2
0.01
73
451
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
11
21
5.69
5.64
1.1
2.2
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
34
148
2.84
5.64
2.6
1.7
s
32.3
29.2
2.32
34
143
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
61
358
2.50
5.49
7.9
3.7
ng/l
50.4
39.7
0.39
51
262
(40760892) CBC W Ordered Manual Differential panel - Blood
39
186
2.66
5.41
7.3
5.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
10
19
5.67
5.14
2.7
1.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
45
240
2.44
4.87
5.8
2.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
40
203
2.49
4.81
1.9
1.5
nmol/l
16.0
20.7
1.15
34
171
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
13
34
4.18
4.68
2.6
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
11
8.76
4.65
3.1
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
14
39
3.95
4.65
2.9
1.9
—
—
—
0
0
(3013512) EKG study
50
286
2.32
4.57
7.0
3.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
49
278
2.33
4.56
4.7
2.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
23
90
2.94
4.56
1.5
1.3
—
—
—
0
0
(3012544) pH of Venous blood
24
97
2.86
4.49
7.9
3.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
25
104
2.79
4.44
1.2
1.1
u/ml
1.0
8.4
—
7
45
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
54
324
2.26
4.36
3.0
2.3
nmol/l
72.0
75.8
0.44
47
283
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
61
385
2.24
4.36
6.4
3.9
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
6
12.30
4.33
3.4
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
46
261
2.27
4.22
9.2
4.0
ph
7.4
7.4
0.02
22
52
(3000991) Gas panel - Venous blood
22
88
2.85
4.18
10.8
5.6
—
—
—
0
0
(3019225) pH of Specimen
20
76
2.98
4.16
10.0
5.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
15
48
3.44
4.10
2.1
2.1
g/l
1.5
1.6
0.13
15
42
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
8
9.22
3.83
3.7
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
7
8
9.22
3.83
1.3
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
27
126
2.49
3.80
2.7
1.9
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
10
25
4.29
3.78
1.0
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
8
12
7.07
3.74
1.3
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
16
6.00
3.74
2.9
1.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
9
17
5.64
3.59
3.1
1.4
—
—
—
0
0
(4062490)
6
6
10.45
3.54
1.2
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
23
103
2.54
3.51
9.8
5.1
mmol/l
-0.5
1.2
0.57
18
84
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
54
346
2.06
3.50
2.2
1.9
pmol/l
95.5
88.7
0.33
27
186
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
18
5.33
3.45
1.0
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
7
8.96
3.30
1.2
1.1
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
6
7
8.96
3.30
1.0
1.9
mg/l
5.5
5.8
—
6
7
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
11
6.69
3.23
1.1
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
20
4.79
3.18
2.9
1.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
22
101
2.46
3.18
2.3
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
8
7.83
3.09
2.0
4.9
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
45
280
2.00
3.09
6.4
3.4
ng/l
3248.2
1534.0
0.71
40
238
(3041096) Erythrocytes [Presence] in Urine by Automated
41
247
2.03
3.08
7.3
3.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
9
21
4.56
3.06
4.6
2.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
36
208
2.06
3.02
4.3
2.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
5
10.37
3.00
4.4
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
5
10.37
3.00
1.2
1.0
iu/ml
184.6
102.5
—
5
5
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
8
17
4.97
2.97
1.3
1.3
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
7
13
5.65
2.91
1.6
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
9
6.96
2.90
2.0
2.0
pg
31.5
32.7
—
6
9
(3035350) Ketones [Presence] in Urine by Test strip
59
411
1.89
2.85
6.4
3.5
estimate
0.0
0.0
0.00
21
79
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
18
4.69
2.85
1.3
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
42
3.07
2.84
14.0
6.9
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
14
54
2.81
2.82
10.7
6.4
%
92.9
94.3
0.64
14
54
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
6
8.64
2.77
1.0
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
6
8.64
2.77
4.4
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
37
223
1.97
2.73
7.4
3.6
estimate
0.0
0.0
0.00
19
81
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
10
6.26
2.73
1.0
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
19
4.44
2.73
3.1
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
20
95
2.34
2.68
2.2
1.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
20
4.22
2.62
2.1
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
6
11
5.68
2.57
3.2
2.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
7
7.40
2.57
1.2
1.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
58
413
1.82
2.53
8.0
5.0
estimate
0.0
0.0
0.00
20
82
(1001926) Buprenorphine [Presence] in Urine by Screen method
7
16
4.58
2.51
2.7
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
12
5.21
2.43
1.2
2.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
17
4.31
2.40
1.9
1.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
58
418
1.78
2.39
6.5
3.6
estimate
0.0
0.0
0.00
21
75
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
102
880
2.41
2.39
51.9
13.7
mg/l
28.1
25.9
0.29
95
700
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
23
122
2.11
2.37
1.3
1.1
iu/ml
15.3
28.2
—
6
41
(3021589) Normoblasts [#/volume] in Blood
58
419
1.78
2.36
27.2
9.1
e9/l
0.0
0.0
0.50
52
346
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
21
109
2.13
2.29
3.7
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
21
110
2.11
2.23
3.8
1.8
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
23
126
2.03
2.18
9.3
4.7
mmol/l
104.6
104.3
0.13
23
121
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
20
3.66
2.09
2.3
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
7
20
3.66
2.09
3.1
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
7
20
3.66
2.09
3.1
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
47
331
1.71
2.02
7.0
3.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
7
21
3.48
2.00
3.1
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
7
21
3.48
2.00
3.1
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
7
21
3.48
2.00
3.1
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
13
58
2.40
1.99
3.0
4.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
22
123
1.98
1.97
30.5
16.8
inr
1.3
1.2
—
7
16
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
11
4.70
1.96
1.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
16
3.89
1.96
1.5
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
30
187
1.82
1.95
4.2
3.0
ng/l
1057.8
191.0
0.63
23
151
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
13
59
2.36
1.92
2.9
1.7
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
40
2.64
1.89
5.8
1.2
g/l
3.9
3.6
—
5
28
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
40
2.64
1.89
5.8
1.2
g/l
8.5
7.3
—
5
29
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
40
2.64
1.89
5.8
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
17
3.66
1.86
1.2
1.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
17
3.66
1.86
1.5
2.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
93
802
1.83
1.78
37.1
14.3
%
37.6
40.4
1.95
47
574
(3045142) Bone marrow Pathology biopsy report
5
13
3.97
1.73
1.2
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
19
3.27
1.68
1.5
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
7
25
2.91
1.68
2.0
1.8
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
92
798
1.76
1.63
5.0
4.0
mu/l
2.2
2.0
0.39
81
697
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
63
500
1.57
1.59
3.4
2.7
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
15
3.43
1.54
1.8
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
74
613
1.58
1.52
4.3
3.3
pmol/l
14.9
14.9
0.02
66
535
(3049717) Cytology report of Urine Cyto stain
9
37
2.55
1.52
1.9
3.0
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
9
39
2.42
1.47
1.7
1.2
u/ml
520.5
143.1
—
9
33
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
8
34
2.45
1.32
2.6
2.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
18
109
1.77
1.28
1.1
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
33
238
1.54
1.22
12.3
6.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
23
152
1.64
1.21
1.4
1.3
u/ml
1.2
1.2
—
8
40
(3012516) Albumin [Mass/volume] in Urine
37
279
1.48
1.10
4.7
3.3
mg/l
1352.4
55.0
0.58
28
193
(4035726)
14
83
1.78
1.07
1.1
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
45
356
1.43
1.04
1.7
2.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
22
2.33
1.04
1.0
1.2
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
104
966
1.80
1.04
50.5
16.7
umol/l
106.3
82.8
1.63
104
966
(3019550) Sodium [Moles/volume] in Serum or Plasma
103
955
1.75
1.02
52.9
15.6
mmol/l
139.3
139.6
0.64
103
922
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
55
453
1.41
1.01
4.4
5.1
ug/l
1.7
3.2
1.22
46
404
(3023103) Potassium [Moles/volume] in Serum or Plasma
103
956
1.74
1.00
53.8
15.8
mmol/l
4.1
4.0
1.75
103
921
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
96
879
1.56
0.96
41.6
13.1
ml/min/173m2
74.0
78.7
0.98
91
711
(3025941) Bacteria identified in Stool by Culture
8
43
1.92
0.89
1.1
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
8
43
1.92
0.89
2.4
2.8
pmol/l
4.2
4.5
—
8
36
(3020682) Albumin/Creatinine [Ratio] in Urine
38
299
1.40
0.89
6.7
4.1
mg/mmol
47.9
8.9
1.39
26
198
(3002256) Pathology report gross observation
17
113
1.59
0.88
1.2
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
8
47
1.75
0.82
4.4
5.3
—
—
—
0
0
(3000492) Spirometry study
12
74
1.69
0.82
1.3
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
30
230
1.41
0.81
1.7
1.6
mmol/l
1.6
1.3
0.84
22
187
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
23
2.23
0.77
1.2
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
24
2.13
0.75
1.2
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
37
298
1.36
0.74
5.1
3.1
mmol/l
6.9
8.1
1.52
28
247
(3022145) Colonoscopy Study observation
15
102
1.54
0.72
1.3
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
26
1.96
0.71
1.2
1.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
7
43
1.67
0.68
7.0
3.0
%
1.6
1.5
—
7
43
(3021879) Hepatitis B virus core Ab [Presence] in Serum
11
71
1.61
0.65
1.1
1.6
—
—
—
0
0
(3020891) Body temperature
6
35
1.75
0.58
3.5
4.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
94
883
1.35
0.56
5.6
4.5
mmol/l
6.3
6.1
0.61
81
784
(40761535) Cells panel - Urine sediment
9
62
1.49
0.54
4.7
3.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
99
939
1.39
0.53
43.1
13.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
27
219
1.30
0.51
1.4
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
90
845
1.30
0.50
8.8
6.1
mmol/mol
43.4
40.5
1.39
82
770
(3044889) 12 lead EKG panel
70
640
1.24
0.48
6.5
3.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
7
48
1.49
0.48
1.9
2.9
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
11
77
1.47
0.47
3.1
2.6
ug/l
6.8
10.3
0.42
11
69
(3035941) MCH [Entitic mass]
105
1012
1.43
0.43
63.9
20.0
pg
30.1
30.4
0.86
105
989
(3024731) MCV [Entitic volume]
105
1012
1.43
0.43
63.9
20.0
fl
91.7
91.1
0.55
105
989
(1761482) Bacteria [#/volume] in Urine by Culture
5
34
1.49
0.41
5.4
6.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
38
333
1.21
0.38
3.9
3.0
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
6
42
1.45
0.36
6.0
2.7
%
0.7
0.7
—
6
42
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
6
45
1.35
0.34
1.5
2.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
23
266
0.83
0.29
2.2
3.0
ug/l
0.7
0.9
0.81
15
180
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
8
105
0.74
0.22
7.9
7.9
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
13
0.00
0.21
0.0
1.2
—
7.6
—
0
6
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6
49
1.24
0.20
1.2
2.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
39
361
1.12
0.18
2.5
4.3
%
22.5
22.3
0.04
20
184
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
90
873
1.14
0.18
4.9
3.9
mmol/l
1.3
1.3
0.44
79
780
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
10
82
1.24
0.17
1.5
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
13
115
1.15
0.11
1.2
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
5
43
1.17
0.10
1.4
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
8
75
1.07
0.07
2.0
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
89
901
0.95
0.04
5.5
4.4
mmol/l
1.3
1.4
1.13
78
808
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
92
927
0.96
0.01
5.8
4.9
mmol/l
2.4
2.7
1.83
79
830
(3011397) Hemoglobin [Presence] in Urine by Test strip
18
177
1.02
0.00
3.7
3.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
90
905
0.97
0.00
5.6
4.4
mmol/l
4.3
4.5
1.40
79
820
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
5
0.00
0.00
0.0
1.2
—
10.7
—
0
5
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
1261.4
—
0
5
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
0.8
—
0
5
(3010838) Calcium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
9.4
—
0.6
—
0
5
(3019420) Tryptase [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
7.5
—
0
7
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(4010399)
6
63
0.95
0.00
1.7
1.4
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
0
6
0.00
0.00
0.0
1.8
—
0.1
—
0
6
(3011648) Oxygen content in Venous blood
0
7
0.00
0.00
0.0
2.1
—
10.8
—
0
7
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
15.3
—
1452.6
—
0
9
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.7
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.8
—
73.7
—
0
6
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
6
59
1.02
0.00
1.0
1.5
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
6
59
1.02
0.00
1.5
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
13.3
—
919.1
—
0
9
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_OSTEOMYELVERTEB and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_OSTEOMYELVERTEB | 1.996 [1.5, 2.65] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.024 |
During the follow-up period (1.1.1998 — 31.12.2019), 121 out of 325 females with M13_OSTEOMYELVERTEB died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_OSTEOMYELVERTEB | 2.433 [1.84, 3.22] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 201 out of 503 males with M13_OSTEOMYELVERTEB died.
Mortality risk
Mortality risk for people of age
years, who have M13_OSTEOMYELVERTEB.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.15% | 0.363% |
| 5 | 0.982% | 2.718% |
| 10 | 2.528% | 6.78% |
| 15 | 4.728% | 12.398% |
| 20 | 8.398% | 20.461% |
Relationships between endpoints
↥Index endpoint: M13_OSTEOMYELVERTEB – Osteomyelitis of vertebra
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data